Allient (ALNT) Financials

$22.43 +0.80 (+3.70%)

Closing price 05/2/2025 04:00 PM Eastern

Extended Trading

$22.45 +0.02 (+0.09%)

As of 04:59 AM Eastern

Annual Income Statements for Allient

This table shows Allient's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	17	24	13
Consolidated Net Income / (Loss)	17	24	13
Net Income / (Loss) Continuing Operations	17	24	13
Total Pre-Tax Income	24	30	17
Total Operating Income	32	42	30
Total Gross Profit	157	184	166
Total Revenue	503	579	530
Operating Revenue	503	579	530
Total Cost of Revenue	346	395	364
Operating Cost of Revenue	346	395	364
Total Operating Expenses	126	141	136
Selling, General & Admin Expense	51	58	56
Marketing Expense	22	25	25
Research & Development Expense	42	46	42
Amortization Expense	11	12	12
Total Other Income / (Expense), net	-7.98	-13	-13
Interest Expense	7.69	12	13
Other Income / (Expense), net	-0.28	-0.23	0.12
Income Tax Expense	6.29	5.60	3.69
Basic Earnings per Share	$1.13	$1.51	$0.80
Weighted Average Basic Shares Outstanding	15.45M	15.96M	16.53M
Diluted Earnings per Share	$1.09	$1.48	$0.79
Weighted Average Diluted Shares Outstanding	15.95M	16.27M	16.60M
Weighted Average Basic & Diluted Shares Outstanding	16.07M	16.59M	16.84M
Cash Dividends to Common per Share	$0.10	$0.12	$0.12

This table shows Allient's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	6.61	3.70	6.32	6.77	6.67	4.35	6.90	1.15	2.10	3.01
Consolidated Net Income / (Loss)	6.61	3.70	6.32	6.77	6.67	4.35	6.90	1.15	2.10	3.01
Net Income / (Loss) Continuing Operations	6.61	3.70	6.32	6.77	6.67	4.35	6.90	1.15	2.10	3.01
Total Pre-Tax Income	9.12	5.11	8.22	8.90	8.66	3.92	8.82	1.45	2.71	3.88
Total Operating Income	12	8.18	11	12	12	7.04	12	4.88	6.62	6.44
Total Gross Profit	43	41	46	46	47	44	47	41	39	38
Total Revenue	134	131	146	147	145	141	147	136	125	122
Operating Revenue	134	131	146	147	145	141	147	136	125	122
Total Cost of Revenue	91	90	100	101	98	97	99	95	86	84
Operating Cost of Revenue	91	90	100	101	98	97	99	95	86	84
Total Operating Expenses	32	33	34	34	36	37	35	36	33	32
Selling, General & Admin Expense	13	13	15	14	15	15	14	14	14	13
Marketing Expense	5.50	5.54	6.03	6.30	6.02	6.36	6.30	6.66	6.32	6.03
Research & Development Expense	9.90	11	11	10	12	13	11	12	9.33	9.56
Amortization Expense	3.05	3.04	3.01	3.14	3.08	3.09	3.12	3.13	3.14	3.12
Total Other Income / (Expense), net	-2.58	-3.07	-3.17	-3.12	-3.21	-3.12	-3.28	-3.43	-3.90	-2.57
Interest Expense	2.34	2.79	2.98	3.16	3.16	3.07	3.39	3.38	3.44	3.09
Other Income / (Expense), net	-0.24	-0.27	-0.19	0.04	-0.04	-0.04	0.11	-0.05	-0.47	0.52
Income Tax Expense	2.51	1.41	1.90	2.13	1.99	-0.42	1.92	0.30	0.61	0.86
Basic Earnings per Share	$0.42	$0.24	$0.40	$0.42	$0.42	$0.27	$0.42	$0.07	$0.13	$0.18
Weighted Average Basic Shares Outstanding	15.66M	15.45M	15.87M	15.97M	15.98M	15.96M	16.39M	16.57M	16.57M	16.53M
Diluted Earnings per Share	$0.41	$0.24	$0.39	$0.42	$0.41	$0.26	$0.42	$0.07	$0.13	$0.17
Weighted Average Diluted Shares Outstanding	16.17M	15.95M	16.14M	16.22M	16.24M	16.27M	16.50M	16.58M	16.61M	16.60M
Weighted Average Basic & Diluted Shares Outstanding	15.89M	16.07M	16.17M	16.18M	16.21M	16.59M	16.78M	16.84M	16.85M	16.84M

This table details how cash moves in and out of Allient's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	8.15	1.29	4.20
Net Cash From Operating Activities	5.60	45	42
Net Cash From Continuing Operating Activities	5.60	45	42
Net Income / (Loss) Continuing Operations	17	24	13
Consolidated Net Income / (Loss)	17	24	13
Depreciation Expense	25	25	26
Amortization Expense	0.20	0.30	0.53
Non-Cash Adjustments To Reconcile Net Income	7.09	9.39	8.97
Changes in Operating Assets and Liabilities, net	-45	-14	-6.71
Net Cash From Investing Activities	-60	-23	-35
Net Cash From Continuing Investing Activities	-60	-23	-35
Purchase of Property, Plant & Equipment	-16	-12	-9.68
Acquisitions	-44	-11	-25
Net Cash From Financing Activities	64	-21	-0.84
Net Cash From Continuing Financing Activities	64	-21	-0.84
Repayment of Debt	-7.98	-28	-72
Payment of Dividends	-1.54	-1.83	-1.98
Issuance of Debt	75	11	77
Other Financing Activities, net	-1.61	-2.10	-4.17
Effect of Exchange Rate Changes	-	-	-1.89

This table details how cash moves in and out of Allient's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Change in Cash & Equivalents	-9.14	11	-5.47	-1.03	-0.28	8.07	-0.39	-0.22	5.83	-1.02
Net Cash From Operating Activities	-5.53	11	3.59	14	9.86	18	9.18	8.20	12	12
Net Cash From Continuing Operating Activities	-5.53	11	3.59	14	9.86	18	9.18	8.20	12	12
Net Income / (Loss) Continuing Operations	6.61	3.70	6.32	6.77	6.67	4.35	6.90	1.15	2.10	3.01
Consolidated Net Income / (Loss)	6.61	3.70	6.32	6.77	6.67	4.35	6.90	1.15	2.10	3.01
Depreciation Expense	6.69	6.26	6.15	6.39	6.42	6.11	6.39	6.42	6.45	6.64
Amortization Expense	0.06	0.08	0.08	0.08	0.08	0.08	0.16	0.11	0.12	0.16
Non-Cash Adjustments To Reconcile Net Income	1.25	2.56	1.66	1.83	1.66	4.24	1.62	3.03	1.98	2.34
Changes in Operating Assets and Liabilities, net	-20	-1.17	-11	-1.38	-4.96	3.14	-5.89	-2.50	1.44	0.24
Net Cash From Investing Activities	-4.70	-4.39	-9.80	-2.56	-6.49	-3.75	-29	-2.06	-1.58	-2.78
Net Cash From Continuing Investing Activities	-4.70	-4.39	-9.80	-2.56	-6.49	-3.75	-29	-2.06	-1.58	-2.78
Purchase of Property, Plant & Equipment	-4.67	-4.88	-3.55	-2.56	-1.73	-3.75	-2.97	-2.36	-1.58	-2.78
Net Cash From Financing Activities	2.18	2.65	0.74	-12	-3.41	-6.82	20	-6.22	-5.63	-8.53
Net Cash From Continuing Financing Activities	2.18	2.65	0.74	-12	-3.41	-6.82	20	-6.22	-5.63	-8.53
Repayment of Debt	-3.11	-1.46	-3.12	-9.45	-9.76	-6.07	-55	-3.80	-5.10	-7.93
Payment of Dividends	-0.37	-0.39	-	-	-0.48	-0.48	-	-	-0.50	-0.48
Other Financing Activities, net	-0.09	-0.28	-0.15	-1.51	-0.17	-0.27	-2.55	-1.47	-0.03	-0.13
Effect of Exchange Rate Changes	-	-	0.01	-0.32	-0.25	-	-0.60	-	-	-2.10

This table presents Allient's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Total Assets	588	598	576
Total Current Assets	236	248	238
Cash & Equivalents	31	32	36
Accounts Receivable	76	85	79
Inventories, net	117	118	112
Prepaid Expenses	12	13	11
Plant, Property, & Equipment, net	69	67	66
Total Noncurrent Assets	284	282	273
Goodwill	126	131	132
Intangible Assets	119	111	100
Noncurrent Deferred & Refundable Income Taxes	4.20	7.76	9.12
Other Noncurrent Operating Assets	34	31	32
Total Liabilities & Shareholders' Equity	588	598	576
Total Liabilities	373	346	311
Total Current Liabilities	88	96	57
Accounts Payable	39	39	27
Accrued Expenses	48	56	30
Total Noncurrent Liabilities	285	250	254
Long-Term Debt	235	218	224
Noncurrent Deferred & Payable Income Tax Liabilities	6.26	4.34	3.64
Noncurrent Employee Benefit Liabilities	3.01	2.68	1.67
Other Noncurrent Operating Liabilities	41	25	24
Commitments & Contingencies	-	0.00	0.00
Total Equity & Noncontrolling Interests	215	252	265
Total Preferred & Common Equity	215	252	265
Preferred Stock	0.00	0.00	0.00
Total Common Equity	215	252	265
Common Stock	84	96	111
Retained Earnings	144	166	177
Accumulated Other Comprehensive Income / (Loss)	-12	-10	-23

This table presents Allient's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024
Total Assets	573	591	585	597	612	596	596
Total Current Assets	227	242	239	245	260	249	251
Cash & Equivalents	20	25	24	24	32	31	37
Accounts Receivable	80	87	87	91	88	82	83
Inventories, net	112	116	116	117	125	122	118
Prepaid Expenses	15	13	12	13	16	14	14
Plant, Property, & Equipment, net	66	69	69	68	70	70	68
Total Noncurrent Assets	280	280	278	284	281	277	277
Goodwill	122	127	128	130	133	133	134
Intangible Assets	121	116	113	114	110	107	105
Noncurrent Deferred & Refundable Income Taxes	3.46	3.98	3.77	3.45	7.13	7.21	7.66
Other Noncurrent Operating Assets	33	33	33	36	31	30	31
Total Liabilities & Shareholders' Equity	573	591	585	597	612	596	596
Total Liabilities	371	361	349	354	344	330	324
Total Current Liabilities	88	87	88	95	73	64	61
Accounts Payable	42	41	42	42	39	33	29
Accrued Expenses	46	46	45	52	34	31	32
Total Noncurrent Liabilities	283	274	261	260	271	266	262
Long-Term Debt	232	237	227	224	240	237	231
Noncurrent Deferred & Payable Income Tax Liabilities	8.91	5.82	6.02	5.80	4.76	4.46	4.08
Noncurrent Employee Benefit Liabilities	3.52	2.82	2.86	2.89	2.78	2.75	2.74
Other Noncurrent Operating Liabilities	39	29	25	27	24	22	24
Total Equity & Noncontrolling Interests	201	230	237	242	267	266	273
Total Preferred & Common Equity	201	230	237	242	267	266	273
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	201	230	237	242	267	266	273
Common Stock	83	92	92	95	110	109	110
Retained Earnings	140	149	156	162	172	173	174
Accumulated Other Comprehensive Income / (Loss)	-22	-12	-11	-15	-15	-16	-12

This table displays calculated financial ratios and metrics derived from Allient's official financial filings.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-
Revenue Growth	24.65%	15.04%	-8.41%
EBITDA Growth	27.95%	18.21%	-16.12%
EBIT Growth	19.07%	34.14%	-28.35%
NOPAT Growth	-14.32%	47.69%	-31.67%
Net Income Growth	-27.83%	38.58%	-45.36%
EPS Growth	-34.34%	35.78%	-46.62%
Operating Cash Flow Growth	-77.97%	704.82%	-7.08%
Free Cash Flow Firm Growth	-27.44%	122.75%	-48.03%
Invested Capital Growth	29.62%	4.23%	3.39%
Revenue Q/Q Growth	7.31%	1.74%	-3.46%
EBITDA Q/Q Growth	10.11%	-1.54%	1.03%
EBIT Q/Q Growth	13.48%	-2.10%	-0.11%
NOPAT Q/Q Growth	21.70%	4.10%	-10.72%
Net Income Q/Q Growth	13.99%	2.78%	-9.20%
EPS Q/Q Growth	12.37%	0.68%	-10.23%
Operating Cash Flow Q/Q Growth	1,736.26%	16.82%	-11.64%
Free Cash Flow Firm Q/Q Growth	48.52%	394.25%	383.24%
Invested Capital Q/Q Growth	1.76%	-1.04%	-3.05%
Profitability Metrics	-	-	-
Gross Margin	31.27%	31.74%	31.26%
EBITDA Margin	11.34%	11.66%	10.68%
Operating Margin	6.29%	7.31%	5.67%
EBIT Margin	6.24%	7.27%	5.69%
Profit (Net Income) Margin	3.46%	4.16%	2.48%
Tax Burden Percent	73.43%	81.13%	78.10%
Interest Burden Percent	75.48%	70.57%	55.91%
Effective Tax Rate	26.57%	18.87%	21.90%
Return on Invested Capital (ROIC)	6.24%	8.00%	5.27%
ROIC Less NNEP Spread (ROIC-NNEP)	2.81%	2.77%	-0.23%
Return on Net Nonoperating Assets (RNNOA)	2.38%	2.32%	-0.17%
Return on Equity (ROE)	8.62%	10.32%	5.10%
Cash Return on Invested Capital (CROIC)	-19.56%	3.86%	1.93%
Operating Return on Assets (OROA)	5.92%	7.10%	5.14%
Return on Assets (ROA)	3.28%	4.06%	2.24%
Return on Common Equity (ROCE)	8.62%	10.32%	5.10%
Return on Equity Simple (ROE_SIMPLE)	8.07%	9.58%	4.97%
Net Operating Profit after Tax (NOPAT)	23	34	23
NOPAT Margin	4.62%	5.93%	4.43%
Net Nonoperating Expense Percent (NNEP)	3.43%	5.23%	5.50%
Return On Investment Capital (ROIC_SIMPLE)	5.16%	7.30%	4.80%
Cost of Revenue to Revenue	68.74%	68.26%	68.74%
SG&A Expenses to Revenue	10.08%	10.09%	10.50%
R&D to Revenue	8.33%	7.94%	7.96%
Operating Expenses to Revenue	24.97%	24.43%	25.60%
Earnings before Interest and Taxes (EBIT)	31	42	30
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	57	67	57
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	2.55	1.94	1.54
Price to Tangible Book Value (P/TBV)	0.00	55.00	12.25
Price to Revenue (P/Rev)	1.09	0.84	0.77
Price to Earnings (P/E)	31.55	20.23	31.07
Dividend Yield	0.29%	0.38%	0.49%
Earnings Yield	3.17%	4.94%	3.22%
Enterprise Value to Invested Capital (EV/IC)	1.79	1.54	1.32
Enterprise Value to Revenue (EV/Rev)	1.50	1.16	1.13
Enterprise Value to EBITDA (EV/EBITDA)	13.20	9.99	10.55
Enterprise Value to EBIT (EV/EBIT)	24.02	16.02	19.80
Enterprise Value to NOPAT (EV/NOPAT)	32.41	19.63	25.45
Enterprise Value to Operating Cash Flow (EV/OCF)	134.65	14.97	14.27
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	40.70	69.38
Leverage & Solvency	-	-	-
Debt to Equity	1.09	0.87	0.85
Long-Term Debt to Equity	1.09	0.87	0.85
Financial Leverage	0.85	0.84	0.73
Leverage Ratio	2.63	2.54	2.27
Compound Leverage Factor	1.98	1.79	1.27
Debt to Total Capital	52.22%	46.47%	45.84%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	52.22%	46.47%	45.84%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%
Common Equity to Total Capital	47.78%	53.53%	54.16%
Debt to EBITDA	4.13	3.24	3.96
Net Debt to EBITDA	3.59	2.77	3.32
Long-Term Debt to EBITDA	4.13	3.24	3.96
Debt to NOPAT	10.13	6.36	9.56
Net Debt to NOPAT	8.81	5.43	8.02
Long-Term Debt to NOPAT	10.13	6.36	9.56
Altman Z-Score	2.56	2.74	2.69
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-
Current Ratio	2.69	2.60	4.14
Quick Ratio	1.22	1.22	2.00
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	-73	17	8.61
Operating Cash Flow to CapEx	35.17%	388.16%	432.20%
Free Cash Flow to Firm to Interest Expense	-9.46	1.34	0.65
Operating Cash Flow to Interest Expense	0.73	3.64	3.15
Operating Cash Flow Less CapEx to Interest Expense	-1.34	2.70	2.42
Efficiency Ratios	-	-	-
Asset Turnover	0.95	0.98	0.90
Accounts Receivable Turnover	7.89	7.17	6.47
Inventory Turnover	3.34	3.36	3.18
Fixed Asset Turnover	8.01	8.50	7.96
Accounts Payable Turnover	9.08	10.05	10.99
Days Sales Outstanding (DSO)	46.24	50.89	56.44
Days Inventory Outstanding (DIO)	109.19	108.49	114.83
Days Payable Outstanding (DPO)	40.21	36.32	33.21
Cash Conversion Cycle (CCC)	115.22	123.06	138.06
Capital & Investment Metrics	-	-	-
Invested Capital	420	438	453
Invested Capital Turnover	1.35	1.35	1.19
Increase / (Decrease) in Invested Capital	96	18	15
Enterprise Value (EV)	753	674	597
Market Capitalization	549	487	409
Book Value per Share	$13.56	$15.52	$15.72
Tangible Book Value per Share	($1.89)	$0.55	$1.98
Total Capital	451	470	489
Total Debt	235	218	224
Total Long-Term Debt	235	218	224
Net Debt	205	187	188
Capital Expenditures (CapEx)	16	12	9.68
Debt-free, Cash-free Net Working Capital (DFCFNWC)	118	121	144
Debt-free Net Working Capital (DFNWC)	148	153	180
Net Working Capital (NWC)	148	153	180
Net Nonoperating Expense (NNE)	5.86	10	10
Net Nonoperating Obligations (NNO)	205	187	188
Total Depreciation and Amortization (D&A)	26	25	26
Debt-free, Cash-free Net Working Capital to Revenue	23.42%	20.85%	27.19%
Debt-free Net Working Capital to Revenue	29.51%	26.36%	34.00%
Net Working Capital to Revenue	29.51%	26.36%	34.00%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	$1.13	$1.51	$0.80
Adjusted Weighted Average Basic Shares Outstanding	15.45M	15.96M	16.53M
Adjusted Diluted Earnings per Share	$1.09	$1.48	$0.79
Adjusted Weighted Average Diluted Shares Outstanding	15.95M	16.27M	16.60M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	16.07M	16.59M	16.84M
Normalized Net Operating Profit after Tax (NOPAT)	23	34	23
Normalized NOPAT Margin	4.62%	5.93%	4.43%
Pre Tax Income Margin	4.71%	5.13%	3.18%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	4.08	3.40	2.27
NOPAT to Interest Expense	3.02	2.77	1.76
EBIT Less CapEx to Interest Expense	2.01	2.46	1.54
NOPAT Less CapEx to Interest Expense	0.95	1.84	1.04
Payout Ratios	-	-	-
Dividend Payout Ratio	8.83%	7.58%	15.05%
Augmented Payout Ratio	8.83%	7.58%	15.05%

This table displays calculated financial ratios and metrics derived from Allient's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	29.85%	35.42%	26.80%	19.59%	8.12%	7.57%	0.80%	-7.32%	-13.84%	-13.47%
EBITDA Growth	38.30%	58.22%	75.75%	25.97%	0.64%	-7.42%	7.62%	-38.72%	-30.60%	4.38%
EBIT Growth	31.67%	89.25%	165.39%	54.70%	3.21%	-11.44%	8.99%	-59.93%	-48.00%	-0.47%
NOPAT Growth	29.73%	219.63%	160.75%	66.49%	7.73%	31.96%	8.19%	-57.64%	-43.91%	-35.79%
Net Income Growth	10.67%	136.71%	152.20%	47.76%	0.86%	17.65%	9.30%	-83.01%	-68.48%	-30.69%
EPS Growth	0.00%	118.18%	143.75%	44.83%	0.00%	8.33%	7.69%	-83.33%	-68.29%	-34.62%
Operating Cash Flow Growth	-260.45%	108.32%	126.77%	4.43%	278.15%	56.80%	155.97%	-40.10%	22.54%	-30.79%
Free Cash Flow Firm Growth	-1,947.16%	-9.38%	25.42%	80.31%	86.52%	88.94%	67.99%	5.55%	5.49%	1.26%
Invested Capital Growth	63.57%	29.62%	24.25%	9.58%	7.17%	4.23%	7.76%	7.17%	5.53%	3.39%
Revenue Q/Q Growth	9.52%	-2.48%	11.04%	0.84%	-0.99%	-2.97%	4.05%	-7.28%	-7.95%	-2.56%
EBITDA Q/Q Growth	23.76%	-21.76%	22.35%	6.34%	-1.13%	-28.03%	42.22%	-39.45%	11.97%	8.25%
EBIT Q/Q Growth	46.90%	-31.02%	41.78%	7.68%	-1.99%	-40.81%	74.49%	-60.41%	27.21%	13.27%
NOPAT Q/Q Growth	54.42%	-30.27%	48.00%	4.47%	-0.08%	-14.59%	21.35%	-59.10%	32.32%	-2.22%
Net Income Q/Q Growth	44.27%	-44.09%	70.91%	7.19%	-1.52%	-34.79%	58.78%	-83.34%	82.70%	43.41%
EPS Q/Q Growth	41.38%	-41.46%	62.50%	7.69%	-2.38%	-36.59%	61.54%	-83.33%	85.71%	30.77%
Operating Cash Flow Q/Q Growth	-142.22%	306.36%	-68.60%	281.68%	-27.97%	81.62%	-48.74%	-10.69%	47.37%	2.57%
Free Cash Flow Firm Q/Q Growth	-2.14%	40.72%	14.10%	62.15%	30.06%	51.36%	-148.59%	-11.69%	30.01%	49.19%
Invested Capital Q/Q Growth	2.92%	1.76%	5.05%	-0.40%	0.66%	-1.04%	8.61%	-0.94%	-0.88%	-3.05%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	32.21%	31.07%	31.49%	31.33%	32.69%	31.47%	32.29%	29.90%	31.36%	31.45%
EBITDA Margin	13.54%	10.86%	11.97%	12.62%	12.61%	9.35%	12.78%	8.35%	10.15%	11.28%
Operating Margin	8.70%	6.24%	7.82%	8.19%	8.16%	4.99%	8.25%	3.59%	5.28%	5.28%
EBIT Margin	8.52%	6.03%	7.70%	8.22%	8.14%	4.96%	8.32%	3.55%	4.91%	5.71%
Profit (Net Income) Margin	4.92%	2.82%	4.34%	4.61%	4.59%	3.08%	4.70%	0.85%	1.68%	2.47%
Tax Burden Percent	72.49%	72.32%	76.83%	76.06%	76.99%	110.81%	78.25%	79.37%	77.44%	77.75%
Interest Burden Percent	79.60%	64.66%	73.37%	73.79%	73.24%	56.07%	72.25%	29.98%	44.13%	55.64%
Effective Tax Rate	27.51%	27.68%	23.17%	23.94%	23.01%	-10.81%	21.75%	20.63%	22.56%	22.25%
Return on Invested Capital (ROIC)	8.89%	6.09%	8.05%	8.26%	8.36%	7.46%	8.16%	3.56%	4.94%	4.88%
ROIC Less NNEP Spread (ROIC-NNEP)	7.65%	4.80%	6.75%	7.08%	7.16%	5.69%	6.94%	2.22%	3.41%	3.82%
Return on Net Nonoperating Assets (RNNOA)	6.35%	4.06%	5.94%	6.52%	6.66%	4.77%	5.86%	1.81%	2.61%	2.77%
Return on Equity (ROE)	15.24%	10.15%	13.99%	14.78%	15.02%	12.23%	14.02%	5.36%	7.55%	7.65%
Cash Return on Invested Capital (CROIC)	-42.50%	-19.56%	-14.44%	-1.46%	0.78%	3.86%	0.17%	-0.35%	0.39%	1.93%
Operating Return on Assets (OROA)	8.53%	5.73%	7.57%	7.89%	7.91%	4.84%	8.02%	3.42%	4.52%	5.16%
Return on Assets (ROA)	4.92%	2.68%	4.27%	4.43%	4.46%	3.01%	4.54%	0.81%	1.54%	2.23%
Return on Common Equity (ROCE)	15.24%	10.15%	13.99%	14.78%	15.02%	12.23%	14.02%	5.36%	7.55%	7.65%
Return on Equity Simple (ROE_SIMPLE)	7.59%	0.00%	9.21%	9.88%	9.68%	0.00%	9.24%	7.18%	5.31%	0.00%
Net Operating Profit after Tax (NOPAT)	8.48	5.91	8.75	9.14	9.13	7.80	9.47	3.87	5.12	5.01
NOPAT Margin	6.31%	4.51%	6.01%	6.23%	6.29%	5.53%	6.45%	2.85%	4.09%	4.11%
Net Nonoperating Expense Percent (NNEP)	1.24%	1.30%	1.31%	1.18%	1.20%	1.77%	1.22%	1.33%	1.53%	1.07%
Return On Investment Capital (ROIC_SIMPLE)	-	1.31%	-	-	-	1.66%	-	-	-	1.02%
Cost of Revenue to Revenue	67.79%	68.93%	68.51%	68.67%	67.31%	68.53%	67.71%	70.10%	68.64%	68.55%
SG&A Expenses to Revenue	9.78%	10.25%	10.18%	9.65%	10.08%	10.48%	9.84%	10.40%	11.07%	10.84%
R&D to Revenue	7.37%	8.04%	7.27%	7.05%	8.19%	9.30%	7.79%	8.72%	7.45%	7.83%
Operating Expenses to Revenue	23.51%	24.84%	23.67%	23.14%	24.52%	26.48%	24.04%	26.32%	26.07%	26.17%
Earnings before Interest and Taxes (EBIT)	11	7.90	11	12	12	7.00	12	4.83	6.15	6.96
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	18	14	17	19	18	13	19	11	13	14
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.26	2.55	2.68	2.71	2.06	1.94	2.21	1.59	1.17	1.54
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	55.00	24.88	16.47	9.44	12.25
Price to Revenue (P/Rev)	0.97	1.09	1.16	1.15	0.88	0.84	1.02	0.74	0.58	0.77
Price to Earnings (P/E)	29.75	31.55	29.11	27.46	21.24	20.23	23.93	22.20	22.06	31.07
Dividend Yield	0.35%	0.29%	0.26%	0.26%	0.36%	0.38%	0.34%	0.48%	0.63%	0.49%
Earnings Yield	3.36%	3.17%	3.44%	3.64%	4.71%	4.94%	4.18%	4.50%	4.53%	3.22%
Enterprise Value to Invested Capital (EV/IC)	1.61	1.79	1.88	1.92	1.58	1.54	1.68	1.33	1.10	1.32
Enterprise Value to Revenue (EV/Rev)	1.42	1.50	1.55	1.52	1.23	1.16	1.38	1.11	0.94	1.13
Enterprise Value to EBITDA (EV/EBITDA)	12.85	13.20	12.83	12.36	10.20	9.99	11.62	10.21	9.18	10.55
Enterprise Value to EBIT (EV/EBIT)	24.08	24.02	21.60	19.83	16.25	16.02	18.55	17.54	17.03	19.80
Enterprise Value to NOPAT (EV/NOPAT)	34.86	32.41	28.94	26.17	21.18	19.63	22.80	21.01	19.57	25.45
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	134.65	36.69	36.49	18.12	14.97	15.79	13.93	10.86	14.27
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	208.50	40.70	1,001.39	0.00	288.70	69.38
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.15	1.09	1.03	0.96	0.93	0.87	0.90	0.89	0.85	0.85
Long-Term Debt to Equity	1.15	1.09	1.03	0.96	0.93	0.87	0.90	0.89	0.85	0.85
Financial Leverage	0.83	0.85	0.88	0.92	0.93	0.84	0.84	0.81	0.77	0.73
Leverage Ratio	2.58	2.63	2.56	2.65	2.64	2.54	2.42	2.35	2.32	2.27
Compound Leverage Factor	2.05	1.70	1.88	1.96	1.93	1.42	1.75	0.70	1.02	1.26
Debt to Total Capital	53.53%	52.22%	50.68%	48.96%	48.09%	46.47%	47.34%	47.13%	45.89%	45.84%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	53.53%	52.22%	50.68%	48.96%	48.09%	46.47%	47.34%	47.13%	45.89%	45.84%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	46.47%	47.78%	49.32%	51.04%	51.91%	53.53%	52.66%	52.87%	54.11%	54.16%
Debt to EBITDA	4.47	4.13	3.66	3.32	3.28	3.24	3.49	3.85	4.13	3.96
Net Debt to EBITDA	4.09	3.59	3.27	2.97	2.93	2.77	3.03	3.34	3.47	3.32
Long-Term Debt to EBITDA	4.47	4.13	3.66	3.32	3.28	3.24	3.49	3.85	4.13	3.96
Debt to NOPAT	12.13	10.13	8.26	7.03	6.80	6.36	6.85	7.91	8.81	9.56
Net Debt to NOPAT	11.10	8.81	7.38	6.29	6.08	5.43	5.95	6.87	7.39	8.02
Long-Term Debt to NOPAT	12.13	10.13	8.26	7.03	6.80	6.36	6.85	7.91	8.81	9.56
Altman Z-Score	2.25	2.43	2.66	2.81	2.54	2.55	2.80	2.53	2.34	2.56
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.58	2.69	2.78	2.73	2.58	2.60	3.56	3.90	4.10	4.14
Quick Ratio	1.13	1.22	1.29	1.27	1.21	1.22	1.63	1.78	1.96	2.00
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-152	-90	-77	-29	-20	-9.97	-25	-28	-19	-9.84
Operating Cash Flow to CapEx	-118.45%	233.82%	100.90%	533.81%	569.23%	477.11%	308.75%	348.11%	767.05%	445.76%
Free Cash Flow to Firm to Interest Expense	-65.06	-32.28	-25.95	-9.27	-6.48	-3.24	-7.31	-8.18	-5.64	-3.19
Operating Cash Flow to Interest Expense	-2.37	4.09	1.20	4.33	3.12	5.83	2.71	2.42	3.52	4.01
Operating Cash Flow Less CapEx to Interest Expense	-4.37	2.34	0.01	3.52	2.57	4.60	1.83	1.73	3.06	3.11
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.00	0.95	0.98	0.96	0.97	0.98	0.96	0.96	0.92	0.90
Accounts Receivable Turnover	6.91	7.89	6.86	7.10	6.67	7.17	6.63	6.71	6.34	6.47
Inventory Turnover	3.52	3.34	3.41	3.35	3.39	3.36	3.27	3.27	3.21	3.18
Fixed Asset Turnover	7.76	8.01	7.93	8.30	8.52	8.50	8.31	8.24	8.06	7.96
Accounts Payable Turnover	8.42	9.08	9.11	8.54	9.21	10.05	9.85	10.34	10.57	10.99
Days Sales Outstanding (DSO)	52.81	46.24	53.22	51.38	54.72	50.89	55.07	54.41	57.57	56.44
Days Inventory Outstanding (DIO)	103.71	109.19	106.96	109.11	107.72	108.49	111.53	111.50	113.63	114.83
Days Payable Outstanding (DPO)	43.36	40.21	40.07	42.76	39.64	36.32	37.05	35.29	34.52	33.21
Cash Conversion Cycle (CCC)	113.16	115.22	120.10	117.73	122.80	123.06	129.55	130.62	136.68	138.06
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	413	420	442	440	443	438	476	471	467	453
Invested Capital Turnover	1.41	1.35	1.34	1.33	1.33	1.35	1.26	1.25	1.21	1.19
Increase / (Decrease) in Invested Capital	161	96	86	38	30	18	34	32	24	15
Enterprise Value (EV)	666	753	828	845	699	674	799	629	514	597
Market Capitalization	454	549	617	642	498	487	591	423	320	409
Book Value per Share	$12.59	$13.56	$14.33	$14.65	$14.97	$15.52	$16.10	$15.84	$16.20	$15.72
Tangible Book Value per Share	($2.63)	($1.89)	($0.77)	($0.27)	($0.12)	$0.55	$1.43	$1.53	$2.01	$1.98
Total Capital	433	451	467	464	467	470	507	503	504	489
Total Debt	232	235	237	227	224	218	240	237	231	224
Total Long-Term Debt	232	235	237	227	224	218	240	237	231	224
Net Debt	212	205	211	203	201	187	209	206	194	188
Capital Expenditures (CapEx)	4.67	4.88	3.55	2.56	1.73	3.75	2.97	2.36	1.58	2.78
Debt-free, Cash-free Net Working Capital (DFCFNWC)	119	118	130	127	126	121	155	154	153	144
Debt-free Net Working Capital (DFNWC)	139	148	155	151	150	153	187	185	190	180
Net Working Capital (NWC)	139	148	155	151	150	153	187	185	190	180
Net Nonoperating Expense (NNE)	1.87	2.22	2.44	2.37	2.47	3.45	2.57	2.72	3.02	2.00
Net Nonoperating Obligations (NNO)	212	205	211	203	201	187	209	206	194	188
Total Depreciation and Amortization (D&A)	6.75	6.34	6.22	6.47	6.50	6.19	6.54	6.52	6.57	6.80
Debt-free, Cash-free Net Working Capital to Revenue	25.47%	23.42%	24.32%	22.83%	22.20%	20.85%	26.79%	27.09%	27.79%	27.19%
Debt-free Net Working Capital to Revenue	29.67%	29.51%	29.04%	27.16%	26.39%	26.36%	32.23%	32.58%	34.55%	34.00%
Net Working Capital to Revenue	29.67%	29.51%	29.04%	27.16%	26.39%	26.36%	32.23%	32.58%	34.55%	34.00%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.42	$0.24	$0.40	$0.42	$0.42	$0.27	$0.42	$0.07	$0.13	$0.18
Adjusted Weighted Average Basic Shares Outstanding	15.66M	15.45M	15.87M	15.97M	15.98M	15.96M	16.39M	16.57M	16.57M	16.53M
Adjusted Diluted Earnings per Share	$0.41	$0.24	$0.39	$0.42	$0.41	$0.26	$0.42	$0.07	$0.13	$0.17
Adjusted Weighted Average Diluted Shares Outstanding	16.17M	15.95M	16.14M	16.22M	16.24M	16.27M	16.50M	16.58M	16.61M	16.60M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.24	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	15.89M	16.07M	16.17M	16.18M	16.21M	16.59M	16.78M	16.84M	16.85M	16.84M
Normalized Net Operating Profit after Tax (NOPAT)	8.48	5.91	8.75	9.14	9.13	4.93	9.47	3.87	5.12	5.01
Normalized NOPAT Margin	6.31%	4.51%	6.01%	6.23%	6.29%	3.50%	6.45%	2.85%	4.09%	4.11%
Pre Tax Income Margin	6.78%	3.90%	5.65%	6.06%	5.96%	2.78%	6.01%	1.07%	2.17%	3.18%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	4.90	2.83	3.76	3.81	3.74	2.28	3.60	1.43	1.79	2.25
NOPAT to Interest Expense	3.63	2.12	2.93	2.89	2.89	2.54	2.79	1.14	1.49	1.62
EBIT Less CapEx to Interest Expense	2.90	1.08	2.56	3.00	3.19	1.06	2.73	0.73	1.33	1.35
NOPAT Less CapEx to Interest Expense	1.63	0.37	1.74	2.08	2.34	1.32	1.92	0.45	1.03	0.72
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	9.90%	8.83%	0.00%	6.98%	7.41%	7.58%	0.00%	10.29%	13.68%	15.05%
Augmented Payout Ratio	9.90%	8.83%	0.00%	6.98%	7.41%	7.58%	0.00%	10.29%	13.68%	15.05%

Frequently Asked Questions About Allient's Financials

When does Allient's financial year end?

According to the most recent income statement we have on file, Allient's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Allient's net income changed over the last 2 years?

Allient's net income appears to be on a downward trend, with a most recent value of $13.17 million in 2024, falling from $17.39 million in 2022. The previous period was $24.10 million in 2023. See Allient's forecast for analyst expectations on what’s next for the company.

What is Allient's operating income?

Allient's total operating income in 2024 was $30.04 million, based on the following breakdown:

Total Gross Profit: $165.69 million
Total Operating Expenses: $135.65 million

How has Allient revenue changed over the last 2 years?

Over the last 2 years, Allient's total revenue changed from $502.99 million in 2022 to $529.97 million in 2024, a change of 5.4%.

How much debt does Allient have?

Allient's total liabilities were at $310.93 million at the end of 2024, a 10.1% decrease from 2023, and a 16.6% decrease since 2022.

How much cash does Allient have?

In the past 2 years, Allient's cash and equivalents has ranged from $30.61 million in 2022 to $36.10 million in 2024, and is currently $36.10 million as of their latest financial filing in 2024.

How has Allient's book value per share changed over the last 2 years?

Over the last 2 years, Allient's book value per share changed from 13.56 in 2022 to 15.72 in 2024, a change of 15.9%.

Related Companies

This page (NASDAQ:ALNT) was last updated on 5/5/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Allient (ALNT) Financials

Frequently Asked Questions About Allient's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Allient (ALNT) Financials

Annual Income Statements for Allient

Quarterly Income Statements for Allient

Annual Cash Flow Statements for Allient

Quarterly Cash Flow Statements for Allient

Annual Balance Sheets for Allient

Quarterly Balance Sheets for Allient

Annual Metrics and Ratios for Allient

Quarterly Metrics and Ratios for Allient

Frequently Asked Questions About Allient's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools